About the role
Do you have expertise in health technology assessment, public reimbursement and market access in Indonesia? If you are passionate about translating scientific evidence into sustainable patient access, AstraZeneca could be the place for you.
ABOUT ASTRAZENECA
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies.
At AstraZeneca, we unlock the power of what science can do. Empowered to explore, everyday we work towards our ultimate aim – treating, preventing, modifying and even curing complex diseases.
BUSINESS AREA - Market Access
Be part of a team working to improve appr opriate and sustainable access to innovative medicines. In Market Access, we connect clinical evidence, health economics, policy insight and stakeholder collaboration to support decisions that can improve patient outcomes. You will work across functions and with external partners to navigate Indonesia’s evolving public-access environment.
What you’ll do
• Lead the development of local health technology assessment (HTA) evidence plans for priority brands, indications and patient needs.
• Partner with qualified HTA agencies and cross-functional colleagues to define study objectives, methodology, evidence gaps, timelines and deliverables.
• Oversee the development and quality review of cost-effectiveness, budget-impact, epidemiology, treatment-pathway, burden-of-disease and relevant real-world evidence analyses.
• Translate clinical and economic evidence into robust, locally relevant HTA dossiers and value stories for technical and non-technical stakeholders.
• Own the country HTA pathway from readiness assessment and dossier planning through submission, clarification, evaluation and follow-through toward FORNAS listing.
• Coordinate timely, high-quality responses to questions from the Ministry of Health, HTA Committee and other relevant review bodies.
• Develop and execute compliant stakeholder engagement plans across relevant government, payer, expert, professional and patient ecosystems.
• Monitor developments related to HTA, FORNAS, JKN/BPJS, pricing, procurement, health financing and competitor access, translating insights into clear recommendations.
• Lead cross-functional access workstreams, ensuring clear governance, responsibilities, timelines, risk management and decision-making.
• Build internal understanding of the HTA pathway, FORNAS process and evolving public-access environment.
Essential for the role
• Bachelor’s degree in pharmacy, medicine, public health, health economics, economics, life sciences or another relevant discipline.
• Relevant experience in market access, HTA, reimbursement, payer engagement, health policy, government affairs or a related pharmaceutical or healthcare role.
• Working knowledge of HTA principles, health economics and the interpretation of clinical and economic evidence.
• Strong understanding of the Indonesian health system and the interfaces among the Ministry of Health, HTA, FORNAS, DJSN, BPJS Kesehatan and public financing stakeholders.
• Demonstrated ability to lead complex, cross-functional evidence or reimbursement projects across multiple stakeholders and deadlines.
• Strong stakeholder engagement, influencing, analytical, problem-solving and project-management capabilities.
• Strong written and verbal communication skills in Bahasa Indonesia and English.
• Sound judgment, attention to detail and a strong commitment to integrity and compliance.
Desirable for the role
• Postgraduate qualification in health economics, public health, epidemiology, pharmacy, m
Apply on employer site ↗